Pharmaceuticals

Global Hyperphosphatemia Drugs Market 2015-2019

  • TEC320910
  • 89 Pages
  • August 2015
  • Pharmaceuticals
About hyperphosphatemia
Phosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.

Technavio's analysts forecast the global hyperphosphatemia drugs market to grow at a CAGR of 10.71% over the period 2014-2019.

Covered in this Report
In this report, Technavio covers the present scenario and growth prospects of the global hyperphosphatemia drugs market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded, generic, OTC, and off-label drugs used for treating hyperphosphatemia.

Technavio's report, Global Hyperphosphatemia Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hyperphosphatemia drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
Americas
APAC
EMEA

Key vendors
Fresenius Medical Care
Keryx Biopharmaceuticals
Sanofi
Shire
Vifor Pharma

Other prominent vendors
Alkem
Amgen
Ardelyx
AstraZeneca
Baxter
Bayer
Chugai Pharmaceutical
Japan Tobacco
Kissei Pharmaceutical
Kyowa Hakko Kirin
Mylan
Natco
Novartis
Opko Health
Panion & BF Biotech
Roxane Laboratories
Sandoz
Synthon
Torri Pharmaceutical

Market driver
Increased number of people undergoing dialysis
For a full, detailed list, view our report

Market challenge
Non-adherence to treatment regimens
For a full, detailed list, view our report

Market trend
Patient assistance programs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Nephrology and Urology Devices Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013 - 2020)

Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Pharmaceutical Contract Manufacturing Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Bio-Banks Market (Equipments, Applications, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Preservation of biological samples such as cells and tissues can be done with the method of low temperature or use of chemicals. Biopreservation systems are becoming popular due to the ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Antiepileptic Drugs Market (Drug Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antiepileptic drugs (AEDs) are commonly termed as anticonvulsants or antiseizure drugs, which are used in symptomatic treatment of epileptic seizures. The epileptic seizures show recurring episodes and occur due to ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>